Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Debt to Equity (2022 - 2025)

PAVmed has reported Debt to Equity over the past 4 years, most recently at $0.5 for Q4 2025.

  • Quarterly results put Debt to Equity at $0.5 for Q4 2025, up 104.27% from a year ago — trailing twelve months through Dec 2025 was $0.5 (up 104.27% YoY), and the annual figure for FY2025 was $0.5, up 104.27%.
  • Debt to Equity for Q4 2025 was $0.5 at PAVmed, up from $0.21 in the prior quarter.
  • Over the last five years, Debt to Equity for PAVM hit a ceiling of $4.1 in Q1 2023 and a floor of -$11.66 in Q4 2024.
  • Median Debt to Equity over the past 4 years was $0.21 (2025), compared with a mean of -$0.66.
  • Biggest five-year swings in Debt to Equity: crashed 653.47% in 2024 and later soared 110.23% in 2025.
  • PAVmed's Debt to Equity stood at $3.08 in 2022, then plummeted by 159.8% to -$1.84 in 2023, then plummeted by 533.78% to -$11.66 in 2024, then skyrocketed by 104.27% to $0.5 in 2025.
  • The last three reported values for Debt to Equity were $0.5 (Q4 2025), $0.21 (Q3 2025), and $0.24 (Q2 2025) per Business Quant data.